findmyKOL

Maya Jerath, MD

Basic profile

Washington University in St. Louis

ORCIDNone on fileNPI
RegionSaint Louis, MO · MidwestSpecialtyAllergy & ImmunologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Maya Jerath is a Rheumatology/Immunology physician affiliated with Washington University in St. Louis. OpenAlex indexes 62 publications with 704 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
62publications

Distinct works indexed by OpenAlex.

704citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

10 Barnes West Dr
Div Im Allergy And Immunology, Ste 200
Saint Louis, MO 631416287

Telephone

314-996-8670

Registry record last updated 17 Apr 2025.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    69.6%
    Integrin Receptor Antagonist69.6%
    Vedolizumab100%
    Part B, office-administered15 patients
  • Anti-infectives

    17.7%
    Human Immunoglobulin G17.7%
    Immune globulin100%
    Part B, office-administered18 patients
  • Musculoskeletal

    10.4%
    RANK Ligand Inhibitor10.4%
    Denosumab100%
    Part B, office-administered32 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”